Genetically modified Super-cells that exploit the full potential of the human immune system – in the eyes of practitioners, a promising Trend in the fight against cancer. Researchers from Seattle in the U.S. state of Washington continue to nourish these hopes now.
You have the genetically engineered immune cells from the human blood stream to regular cancer-destroyers converted. With this the Doctors within weeks to release a Test-patients of cancer of the Lymph nodes. “The cancer is melting literally before,” reported Ken Shefveland the Associated Press (AP) of the treatment.
But also from the medical side and from the novel therapy proved to be extremely successful. At follow-up four weeks after start of therapy, his Doctors found no cancer-symptoms more in the body of the man. “I can say that I am completely healed. How wonderful is this?“ Patient Ken Shefveland says.
Immune therapy opens of cancer medicine, the new healing methods
The therapy-Experiment could be a starting point for a completely new Form of cancer treatment – and on top of that, a very efficient. Prior to the pioneering treatment of Shefveland first test series were carried out with a so-called CAR-T-cells in humans.
Put simply, These cells can be selected by medical professionals depending on your needs in a modular way. For example, with elements that detect cancer cells – and then deliberately destroy. In the first Tests, the modified unfolded, more powerful immune cells in leukemia and cancer of the Lymph nodes patients healing effect.
Anti-cancer cell “shows the incredible power of the immune system”
Dr. David Maloney, who is head of the cancer research Institute, the Department of immune therapy, is therefore enthusiastic about the CAR-T-cells-treatment: “It shows the incredible power of the immune system.” His colleague, Dr. Stanley Riddell is expressed to the AP is critical. “There is still much to learn,” he says.
The Doctors are faced with the task of understanding life-threatening side effects and to get under control. Among other things, it apparently comes to physically demanding over-stimulated formulations of the immune system. Also, it came with previous therapies already cases of death, as AP reported, citing companies that are experimenting with the Immune-therapy.
Research is still “a Model is A Ford"
However, the first immune cell therapies may come in the course of the year 2017 in more clinics. But only for a few, certain forms of blood cancer. The US drug control authority is currently deciding whether two limited effective forms of treatment that are licensed by the pharmaceutical company Novartis and Kite pharmaceuticals, are already ready for the market and no complications cause.
The current state of the research corresponds approximately to “a Model A Ford, but we need a Lamborghini”, dampens the CAR-T-cells-researcher Dr. Renier Brentjens to high expectations. The theoretical possibilities are, however, unmanageable large.